News Focus
SPONSORED
News Focus
SPONSORED
Spot liquidity moves with access to US order books.
What's the plan to get this stock moving up again? It's been idle for too long.
Yeah and flashy videos being released at the same time as 5 million shares hit DTC. They are trying to pump this so they can dump those shares into retail.
Do you run OSR Holdings Inc?
Sir, I am not pumping a thing. The study results will tell you everything. It's as simple as that. They are on clinicaltrials.gov so it's legit science.
Here comes the pump squad. eqinvestor just came on board out of the blue?
Totally Agree! Big Things from an under the radar company! We will be noticed soon enough! Cutting edge research with Cutting edge positive results!
And the news today confirms the cutting edge research
Company with tiny market cap appears to be doing cutting edge research.
Gotta put out news so those fresh 5m that hit DTC can sell. Robbie and Miguel gonna get paid.
$ADIA NEWS https://www.newsfilecorp.com/release/307043
It will be interesting to see the most recent quarter Financials to compare to last quarter's numbers. Currently, adiamed is slowly sliding downhill.
It's either Jaguar or the company itself to make it seem like there's a market
Someone keeps "marking the close" almost daily. Not a good sign. Repels new investors.
Not even going to come close to Nasdaq. The CEO has a prior SEC litigation judgement against him and they sold shares in this to the guy that lives down the street from him for a massive discount. Its all a sham
My biggest concern is a reverse stock split to get to the Nasdaq. If this happens the current stockholders are screwed.
And with those 5 million shares now available to be sold this will probably drop further. They got those shares at .005 I believe.
Zero interest for months. Very disappointing. Losing my interest very fast. Time for me to move on. GLTA
5 million shares added to DTC yesterday. Looks like Robbie and Miguel are getting ready to dump on you guys.
The pps doesn't support your claims yet. Until I see a large improvement in the pps I still have my concerns.
I hope AdiaMed kicks into gear soon.
ADIA Med Inc. Is way ahead of everyone else in the clinical trials using stem cells! Several studies have already started and others in the works.
Great time to add shares! I added more on the cheap .10- .13
So far only selling going on. This needs to do a 180 soon. Still no interest or volume. There's a "huge" gap between now and a nasdaq listing.
Exciting Times for ADIA MED!
🚀 Adia Med ($ADIA) is on a tear!
— Adia Med Inc. (formally Adia Nutrition Inc.) (@adia_med) July 13, 2026
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ 👇https://t.co/TJ4isdBsfU #HealthCare #OTC #OTCMarkets #OTCStocks #Investing
When is this company going to get some legs? It's been months since we've seen any volume and/or interest.
Adia Nutrition Inc changed to Adia Med Inc
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Adia Med Inc! Love it! Let's Goooo ADIA MED INC.!
$ADIA PRESS RELEASE
— Adia Med Inc. (formally Adia Nutrition Inc.) (@adia_med) July 9, 2026
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Reviewhttps://t.co/cVZXWktBbK#AdiaMed #FINRA #OTC #OTCMarkets #Investing #HealthCare
Thank you @jrlsss for the balanced analysis.
We appreciate the thoughtful feedback.
A few points of context:
On the positives you noted:
We became a fully reporting SEC company earlier this year, which has increased transparency. We have active IRB-approved clinical studies currently enrolling or advancing (including lower back pain with AdiaVita and autism research), all conducted under medical supervision. Through Adia Labs, we are also expanding B2B opportunities with our biologic products.
Regarding the challenges:
As a small company in regenerative medicine, some volatility is expected. However, we do not anticipate any additional capital raises. Our last raise was over a year ago. Instead of focusing on rapid clinic expansion, our priority is advancing clinical studies to support Section 361 compliance. This approach is intended to generate the data needed for potential insurance reimbursement and broader patient access.Our model combines clinical research with B2B biologic sales, which has already driven strong revenue growth (approximately $700k in 2025). We encourage investors to review our latest SEC filings and visit adiamed.com for details on our studies and operations.
Happy to answer any specific questions here or through official channels at research@adiamed.com.
Here's how I see AdiaMed:
Pros:
- Fully reporting SEC status
- Clinical trial & study infrastructure
- B2B expansion
Cons:
- Penny stock volatility
- Capital dilution
-Regulatory dependency (section 361)
This company is a highly speculative buy for high-risk investment. Things to look for is cash burn, revenue growth, and clinical study results. If successful, there can be high rewards, but AdiaMed deals with localized regenerative clinics rather than billion-dollar molecular lab drug pipelines. JMO
Love the Reply! Good stuff happening! Takes time, Let's go ADIA!
I get the frustration — clinic launched ~17 months ago and price is still in the teens despite the PR.Quick update: Name change to Adia Med Inc. was officially approved in Nevada June 10. New subsidiary ADIA Life LLC launched June 8 to scale product distribution.
PR helps awareness, but in early-stage regenerative medicine, the share price usually follows revenue growth and execution. Market cap is still low (~$15-16M).
Adia is working on both.
Adia is also looking for a new IR and marketing group.
Watch for results as Adia scales.
Not financial advice — DYOR.
I appreciate all the good PR but when is the pps going to move up? It's been almost 1 1/2 years since the launch. I was hoping to be $1.00+ by now but still sitting in the teens.
Lookin Good! Go ADIA Med Inc.!
$ADIA PRESS RELEASE
— Adia Med Inc. (formally Adia Nutrition Inc.) (@adia_med) June 10, 2026
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada https://t.co/fsz2RvOrCE #AdiaLabs #AdiaMedInc #clinicalstudy #regenerativemedicine #stemcells #HealthCare #Nevada #OTC #OTCMarkets #OTCStocks #Investing
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC
☀️MS Recovery: Stem Cells, Hope, and New Beginnings
— Adia Med Inc. (formally Adia Nutrition Inc.) (@adia_med) June 8, 2026
Forever grateful to Larry’s incredible commitment to helping others — all because of his own battle with MS.
His story is proof that healing and new beginnings are possible!
Watch the full short here👇…
$ADIA PRESS RELEASE
— Adia Med Inc. (formally Adia Nutrition Inc.) (@adia_med) June 8, 2026
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions https://t.co/bLArn4xHYr #adialabs #adialife #nutrition #stemcells #wellness #HealthCare #OTC…
Please educate yourself on Umbilical Stem Cells and Glutathione Peptides! Proof that these combinations work wonders is Coming! Patience is Key! In for the Long Haul. I use peptides for my sports injuries and boy do they work. My brother is an RN and he knows how great these peptides are.
As matter of fact, my dad had lower back surgery and has chronic lower back pain. He Began using peptides Wolverine Stack with Glutathione and has helped him tremendously over other medications he was taking. So much so that he can now get up and walk more without so much pain. So ADIA will be successful! Good luck Everyone!
There isn't anyone on this board other than you that I communicate with. Not worth my time.
Time will tell what direction this company will go. I'll give it some time to see what you can accomplish. I'll know soon enough.
Not sure where that prediction came from.
Without saying too much.
I think you'll be very impressed with the direction Adia is going.
Predictions by who? The CEO or Jaguar? Both are pumping this crap. It wont see NASDAQ. The guy has a judgement with the SEC back in the day. You think SEC wont take that into account if they attempt to uplist?
Appreciate your explanation. If only the investors could understand the difference.
There needs to be a way to obtain interest so this company can get out of their rut.
NASDAQ is a long way away. Predictions of $1.68 beginning this summer was done a few months ago and we're still in the $.12-$.15 range with very small volume.
|
Followers
|
99
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8520
|
|
Created
|
04/12/10
|
Type
|
Free
|
| Moderators Jaguarjacket samson8 | |||
Meta (NASDAQ:META) launched a new open-weight artificial intelligence model on Monday as CEO Mark Zuckerberg called for the United States to reduce barriers facing domestic developers in order to compete more effectively with Chinese rivals. The new model, called Muse Glimmer, is considerably smaller than the flagship AI systems developed by leading competitors. Rather than […]
| Volume | |
| Day Range: | |
| Bid Price | |
| Ask Price | |
| Last Trade Time: |